Aspen Neuroscience
124 employees
Biotech/Pharma
Series C · $340.0M
Open positions (5)
Company details
Team Size124
IndustryBiotech/Pharma
Funding
Total raised
$340.0M
Last stage
Series C
Investors
Frazier Life Sciences
Total raised
$340.0M
Last stage
Series C
Investors
Jeanne Loring
World-renowned stem cell scientist whose groundbreaking research at the Scripps Research Institute formed the scientific foundation for Aspen Neuroscience's iPSC-derived dopaminergic neuron platform.
Andrés Bratt-Leal
Co-founder who served as a post-doctoral fellow in Jeanne Loring's lab and helped develop the core iPSC-to-dopaminergic neuron technology underlying Aspen. Holds a PhD in Biomedical Engineering from Georgia Tech.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.